The impact of clinical sample collection timing on FRα expression and mirvetuximab soravtansine patient outcomes in the MIRASOL (GOG 3045/ENGOT-ov55) trial

S Kommoss, S C Cecere, O Tredan, E Teplinsky, A Santaballa, G Jayson, A Santin, G Huygh, N Cloven, J-W Lee, S Derio, D Klasa-Mazurkiewicz, I Boere, S Breuer, Y Zhuo, T Piatnytska, Z Li, E Deutschman, D Berton, C Anderson · Geburtshilfe und Frauenheilkunde · 2026 · Heft 10 · S. e146-e147